Search
Explore Johnson Matthey's website
Showing results 401-408 / 483
Independent trials confirm greater benefits of HTX thermocouple wire over conventional thermocouples
News: Independent trials at the UK’s National Measurement Institute, NPL, confirm that HTX thermocouple wire maintains its accuracy for longer than conventional thermocouples.
ExploreThe importance of solid form science in modern drug development
As the pharmaceutical industry turns to more complex chemical entities with increased molecular weight, enhancing solubility is becoming a key drug development challenge.
ExploreAdvancing the hydrogen economy from production to application
What are JM's activities across the hydrogen value chain? JM's CTO, Maurits van Tol, speaks to Hydrogen Central.
ExploreJohnson Matthey partners with Immunomedics to develop life-saving cancer treatment
News: Johnson Matthey has announced a strategic manufacturing partnership for the large-scale production of the drug-linker used in Immunomedics’ lead antibody-drug conjugate.
ExploreIf hydrogen is the answer to energy security, let's talk carbon, not colour
Maurits van Tol, Chief Technology Officer, explains why we need a change of language to enable development of a global clean hydrogen economy.
ExploreDayle van Morgen
See what Dayle van Morgen has to say about their time at JM and what they think about the company.
Explore
